Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AURO LAB. vs SUVEN PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AURO LAB. SUVEN PHARMACEUTICALS AURO LAB./
SUVEN PHARMACEUTICALS
 
P/E (TTM) x 21.2 135.7 15.6% View Chart
P/BV x 3.1 16.1 19.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AURO LAB.   SUVEN PHARMACEUTICALS
EQUITY SHARE DATA
    AURO LAB.
Mar-24
SUVEN PHARMACEUTICALS
Mar-24
AURO LAB./
SUVEN PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs178767 23.2%   
Low Rs53375 14.2%   
Sales per share (Unadj.) Rs86.141.3 208.5%  
Earnings per share (Unadj.) Rs12.511.8 106.0%  
Cash flow per share (Unadj.) Rs14.313.9 102.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs67.380.5 83.7%  
Shares outstanding (eoy) m6.23254.57 2.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.313.8 9.7%   
Avg P/E ratio x9.248.4 19.1%  
P/CF ratio (eoy) x8.141.0 19.8%  
Price / Book Value ratio x1.77.1 24.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m720145,357 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m391,359 2.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53610,514 5.1%  
Other income Rs m15619 2.4%   
Total revenues Rs m55111,133 5.0%   
Gross profit Rs m1074,058 2.6%  
Depreciation Rs m11546 2.0%   
Interest Rs m775 9.9%   
Profit before tax Rs m1034,057 2.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m261,054 2.4%   
Profit after tax Rs m783,003 2.6%  
Gross profit margin %19.938.6 51.5%  
Effective tax rate %24.726.0 95.0%   
Net profit margin %14.528.6 50.9%  
BALANCE SHEET DATA
Current assets Rs m30913,623 2.3%   
Current liabilities Rs m2392,061 11.6%   
Net working cap to sales %12.9110.0 11.7%  
Current ratio x1.36.6 19.5%  
Inventory Days Days0318 0.1%  
Debtors Days Days911464 196.4%  
Net fixed assets Rs m5499,909 5.5%   
Share capital Rs m62255 24.5%   
"Free" reserves Rs m35720,232 1.8%   
Net worth Rs m42020,487 2.0%   
Long term debt Rs m1840-   
Total assets Rs m85723,532 3.6%  
Interest coverage x15.155.4 27.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.60.4 140.0%   
Return on assets %9.913.1 76.1%  
Return on equity %18.614.7 126.7%  
Return on capital %18.420.2 91.1%  
Exports to sales %88.20-   
Imports to sales %26.40-   
Exports (fob) Rs m473NA-   
Imports (cif) Rs m142NA-   
Fx inflow Rs m47310,857 4.4%   
Fx outflow Rs m1472,119 6.9%   
Net fx Rs m3268,737 3.7%   
CASH FLOW
From Operations Rs m1883,585 5.2%  
From Investments Rs m-387-3,623 10.7%  
From Financial Activity Rs m191-138 -138.3%  
Net Cashflow Rs m-8-176 4.4%  

Share Holding

Indian Promoters % 52.2 0.0 -  
Foreign collaborators % 0.0 50.1 -  
Indian inst/Mut Fund % 0.0 27.7 0.0%  
FIIs % 0.0 10.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 47.9 49.9 95.9%  
Shareholders   9,266 69,337 13.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AURO LAB. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on AURO LAB. vs SUVEN PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AURO LAB. vs SUVEN PHARMACEUTICALS Share Price Performance

Period AURO LAB. SUVEN PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day 4.98% 0.01% 0.87%
1-Month -5.07% 3.70% 1.19%
1-Year 54.42% 99.84% 46.16%
3-Year CAGR 24.98% 36.37% 19.61%
5-Year CAGR 29.90% 50.44% 26.11%

* Compound Annual Growth Rate

Here are more details on the AURO LAB. share price and the SUVEN PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of AURO LAB. hold a 52.2% stake in the company. In case of SUVEN PHARMACEUTICALS the stake stands at 50.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AURO LAB. and the shareholding pattern of SUVEN PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, AURO LAB. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

SUVEN PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of AURO LAB., and the dividend history of SUVEN PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.